Journal · Updated 2026-08-11
Why Compounded GLP-1s Come With B12 (or Glycine): What the Additives Do, and What They Don't
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
The additive is doing three jobs, none of them the one the marketing implies. Compounders blend GLP-1s with cyanocobalamin (B12) — or, for patients who react to B12, alternatives like glycine with B6 — for formulation and differentiation reasons: a carrier that gives the preparation a compounding rationale, a tolerability story (B12's marketed nausea-support role, on thin evidence), and — the load-bearing one post-shortage — a formulation that is not an exact copy of the approved product, which matters under the 503A framework's essentially-a-copy restrictions when paired with a prescriber's documented patient-specific rationale. What the additive does not do: no evidence shows B12 or glycine enhances GLP-1 weight loss, and marketing that leans on "boosted energy and results" is selling the vitamin's reputation, not a trial. The blend is mostly harmless, occasionally informative, and never the reason to choose a program.
What each ingredient plausibly contributes
B12 (cyanocobalamin) is water-soluble, cheap, and famously safe at these doses — excess simply excretes — and its inclusion carries a soft clinical story: appetite-suppressed patients eat less of everything including B12 sources, and B12 has a folk-and-fragment evidence role in nausea support. Neither claim is trial-grade for this use; neither is implausible; neither moves weight. Glycine plus B6 exists mainly as the answer to "what if the patient reacts to B12" — the competitor materials in this market describe it exactly that way — with glycine as an amino-acid carrier and B6 riding the same nausea-adjacent folklore. Injection-site comfort and formulation stability claims attach to both blends at the anecdote level. The honest summary a pharmacist would sign: the additives are benign passengers with a marketing seat upgrade.
The regulatory subtext, and the questions that matter more
Post-shortage, a 503A pharmacy compounding a GLP-1 needs the preparation to serve a documented patient-specific need rather than duplicate the approved product — and a B12-blended, differently-concentrated formulation, prescribed with an individualized rationale, is a cleaner fit for that framework than a bare copy would be. That's context for why the blends are near-universal, not an accusation: the same formulation can be simultaneously a compliance posture and a genuine prescriber choice, as our microdosing analysis found for dosing tiers. What it means for you is a re-ordering of questions. Don't ask "does it have B12" — ask the ones that separate pharmacies: base-form semaglutide or tirzepatide, not a salt? (the FDA's specific chemistry flag). What exact concentration, on the label? (your units math depends on it). Certificate of analysis for my lot? And if you have a known B12 sensitivity or are on interacting therapy, say so at intake — the glycine formulations exist for exactly that answer. The vitamin is the least important word on the vial; this page exists so it stops being the most persuasive one.
Questions people ask
Does the B12 in compounded semaglutide help with weight loss?
No evidence supports enhanced weight loss from B12 (or glycine/B6) blending — the additives are formulation carriers with a soft tolerability story and, post-shortage, a regulatory role in making the preparation not an exact copy of the approved product. They're benign passengers; the GLP-1 does the work.
Why do compounded GLP-1s contain B12 at all?
Three duller-than-marketed reasons: a carrier/formulation role, a thin-evidence nausea-support and 'you're eating less B12 sources' story, and — the load-bearing one — differentiation from the approved product under the 503A framework's essentially-a-copy restrictions, alongside a prescriber's documented patient-specific rationale.
What if I'm sensitive to B12 — can I still get compounded tirzepatide?
Yes — alternative formulations exist for exactly this, typically glycine with B6 as the carrier (competitor pharmacies in this market describe offering both for that reason). Say so at intake; the pharmacy formulates accordingly. The questions that matter more than the carrier: base-form active ingredient, labeled concentration, and a certificate of analysis.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.